FSR is pleased to announce the 2021 Small Research Grant Awardees. As part of our mission, FSR accelerates sarcoidosis research through fellowships, small grants, and large grant programs, and has dedicated over $5M million for worldwide sarcoidosis research since...
On September 13, 2021, aTyr Pharma announced positive results from their Phase1b/2a clinical trial for ATYR1923 in pulmonary sarcoidosis. FSR is proud to have supported this clinical trial. The trial demonstrated that ATYR1923 was safe and well-tolerated, 33%...
The Foundation for Sarcoidosis Research (FSR) is pleased to announce the Foundation for Sarcoidosis Research Fellowship Grant for 2021-2023 is being awarded to Dr. Paula Berreras from Johns Hopkins University Hospital for her project, “Discovering pathogens in...
Authors: Arindam Singha, MD1; Tricha Shivas, MBe2 ; Elliot D. Crouser, MD1 Since it was declared a global pandemic in March of 2020, the coronavirus disease 2019 (COVID-19) has affected over 100 million lives globally. It has been demonstrated that patients...
Early Investigator Grant Opportunity The Foundation for Sarcoidosis Research (FSR) is seeking proposals from US-based early-stage investigators for a grant that provides support for a collaborative and translational research project that will positively impact...
Xentria Inc. has recently announced they received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for their intravenous TNF-inhibitor, XTMAB-16. The FDA grants orphan status to drugs being developed to treat those with rare diseases. This...
Program supports specialized skill development of early-career physicians and researchers interested in studying sarcoidosis CHICAGO, Dec. 17, 2020 /PRNewswire/ — The Foundation for Sarcoidosis Research (FSR) is pleased to announce the opening of a new...
FSR’s Small Grant Program The FSR Small Grant aims to support smaller scale or pilot research projects, which can be supported either singularly by FSR or through a partnership with additional funders. The goal of this program is to provide bridge funding for...
FSR launched its Clinical and Research Fellowship Program in Fall 2017. We’ve invested over $1 million into this program, which aims to increase the number of specialized doctors and researchers in the sarcoidosis space. This investment in early career...
Sarcoidosis is difficult to treat for many reasons. Mainly, there is not one clear way to treat sarcoidosis because it manifests in many forms and the cause is unknown. For this reason, there are also many ways to diagnose sarcoidosis, making it a diagnosis of...
